Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Whole Foods knocked down in court again

This article was originally published in The Tan Sheet

Executive Summary

The U.S. District Court for the District of Columbia rules Jan. 8 that the Federal Trade Commission showed the "likelihood of success" in its antitrust case against the merger of supermarket chains Whole Foods and Wild Oats Markets. The next step is to weigh the merits of the case and, "if they favor the FTC, to determine the appropriate remedies" since "the merger already has gone forward," the court says. The parties are to propose a method of proceeding by Jan. 16. The decision agrees with a July 2008 appeals court ruling that remanded the case to the district, which had originally favored Whole Foods (1"The Tan Sheet" Aug. 4, 2008, In Brief)

You may also be interested in...

Merger indigestion

The U.S. Court of Appeals for the District of Columbia Circuit reverses a district court ruling that denied a Federal Trade Commission injunction against Whole Foods' purchase of Wild Oats Markets. According to the July 29 1decision, the lower court erred in finding the merger could not result in a monopoly in any relevant product market because FTC would never be able to adequately define the "premium, natural and organic supermarkets" sector. The appeals decision says the district court "underestimated" the likelihood in FTC defining the PNOS market. FTC's general counsel July 30 said Whole Foods can seek a rehearing in the D.C. circuit before the same panel or en banc, submit a writ of certiorari to be heard by the Supreme Court or return to the district court to argue the case under the guidelines set in the appeals court decision. No ruling yet has ordered a halt to Whole Foods' $565 million purchase of Wild Oats, which was completed in September 2007 (2"The Tan Sheet" Sept. 3, 2007, In Brief)...

Centus Gets European Bevacizumab Approval

Centus Biotherapeutics has received formal European Commission approval for its Equidacent biosimilar rival to Avastin.

IGBA Calls For ‘Streamlining’ Of Global Biosimilars Process

The IGBA has called for a “streamlined” global biosimilar development and registration process, with a new policy paper highlighting the limited value of comparative efficacy clinical data at the same time as it urges renewed efforts on educating healthcare professionals.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts